Lifesaving leukemia treatment now available in Wichita
Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of ...
Healio2d
VIDEO: Study results ‘solidifying’ role of blinatumomab treatment in pediatric ALL
In this video, Marlise R. Luskin, MD, MSCE, discusses results from a phase 3 randomized trial that investigated the addition of blinatumomab to standard chemotherapy for pediatric B-cell acute ...
Healio2d
VIDEO: ‘Encouraging’ data from two groups assessing blinatumomab, ponatinib in ALL
In this video, Marlise R. Luskin, MD, MSCE, highlights updates from two groups evaluating blinatumomab and ponatinib for the treatment of acute lymphoblastic leukemia.
Hosted on MSN7d
Groundbreaking pediatric leukemia treatment now available in Wichita
KU School of Medicine-Wichita Department of Pediatrics and Wesley Children’s Hospital say a groundbreaking treatment for ...
MedPage Today1mon
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
Opens in a new tab or window A study presented at the American Society of Hematology annual meeting identified TCL1A as a potential predictive biomarker for blinatumomab (Blincyto) response in ...